EDP Sciences logo
Subscriber Authentication Point
Rechercher
Menu
Accueil Tous les numéros Volume 41 / Numéro 12 (Décembre 2025) Med Sci (Paris), 41 12 (2025) 1004-1008 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 12, Décembre 2025
La santé des femmes : au-delà de la procréation
Page(s) 1004 - 1008
Section Ménopause
DOI https://doi.org/10.1051/medsci/2025228
Published online 6 janvier 2026
  1. Murabito JM, Yang Q, Fox C, et al. Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab 2005; 90 : 3427–30. [Google Scholar]
  2. Zhu D, Chung HF, Pandeya N, et al. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies. PLoS Med 2018; 15 : e1002704. [Google Scholar]
  3. Beyene Y. Cultural significance and physiological manifestations of menopause. A biocultural analysis. Cult Med Psychiatry 1986; 10 : 47–71. [Google Scholar]
  4. LOCK M. Culture politique et vécu du vieillissement des femmes au Japon et en Amérique. Sociologie et sociétés 1996; 28 : 119–40. [Google Scholar]
  5. Charlap C. La fabrique de la ménopause : genre, apprentissage et trajectoires. Université de Strasbourg, 2015. [Google Scholar]
  6. Tillier A. Un âge critique. La ménopause sous le regard des médecins des XVIIIe et XIXe siècles. Clio 2005; 21 : 269–80. [Google Scholar]
  7. Longrois JBCJ. Conseils aux femmes de quarante ans. chez Méquignon, Libraire, 1787. [Google Scholar]
  8. WH U. The estrogen elixir: A history of hormone replacement therapy in America. J Clin Invest 2008; 118. [Google Scholar]
  9. Wilson RA. Feminine forever. New York : Evans 1966 : 224p. [Google Scholar]
  10. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. Jama 2002; 288 : 321–33. [Google Scholar]
  11. Watkins ES. “Doctor, are you trying to kill me?”: ambivalence about the patient package insert for estrogen. Bull Hist Med 2002; 76 : 84–104. [Google Scholar]
  12. Valéra MC, Fontaine C, Noirrit-Esclassan E, et al. Vers une optimisation de la modulation du récepteur des œstrogènes dans le traitement hormonal de la ménopause. Med Sci (Paris) 2018; 34 : 1056–62. [Google Scholar]
  13. Trémollieres FA, André G, Letombe B, et al. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management. Maturitas 2022; 166 : 58–64. [Google Scholar]
  14. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007; 10 : 197–214. [Google Scholar]
  15. Green R, Santoro N. Menopausal symptoms and ethnicity: the study of women’s health across the nation. Womens Health (Lond) 2009; 5 : 127–33. [Google Scholar]
  16. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015; 175 : 531–9. [Google Scholar]
  17. Modi M, Dhillo WS. Chapter 30 - The neuroendocrinology of the preoptic area in menopause: symptoms and therapeutic strategies. In : Swaab DF, Kreier F, Lucassen PJ, Salehi A, Buijs RM, eds. Handbook of Clinical Neurology : Elsevier, 2021 : 455–60. [Google Scholar]
  18. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health 2007; 10 : 247–57. [Google Scholar]
  19. Sharif A, Prévot V. Les neurones produisant la gonadolibérine sculptent leur environnement neuroglial dans la petite enfance. Med Sci (Paris) 2022; 38 : 428–30. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  20. Rance NE, Dacks PA, Mittelman-Smith MA, et al. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes. Front Neuroendocrinol 2013; 34 : 211–27. [Google Scholar]
  21. Rance NE, Young WS, 3rd. Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women. Endocrinology 1991; 128 : 2239–47. [Google Scholar]
  22. Abel TW, Voytko ML, Rance NE. The effects of hormone replacement therapy on hypothalamic neuropeptide gene expression in a primate model of menopause. J Clin Endocrinol Metab 1999; 84 : 2111–8. [Google Scholar]
  23. Mittelman-Smith MA, Williams H, Krajewski-Hall SJ, et al. Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. Proc Natl Acad Sci U S A 2012; 109 : 19846–51. [Google Scholar]
  24. Conklin M, Santoro N. Neurokinin receptor antagonists as potential non- hormonal treatments for vasomotor symptoms of menopause. Ther Adv Reprod Health 2023; 17 : 26334941231177611. [Google Scholar]
  25. Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet 2023; 401 : 1091–102. [Google Scholar]
  26. Pinkerton JV, Simon JA, Joffe H, et al. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. Jama 2024; 332 : 1343–54. [Google Scholar]
  27. Lee E, Anselmo M, Tahsin CT, et al. Vasomotor symptoms of menopause, autonomic dysfunction, and cardiovascular disease. Am J Physiol Heart Circ Physiol 2022; 323 : H1270–h80. [Google Scholar]
  28. Thurston RC, Aslanidou Vlachos HE, Derby CA, et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. J Am Heart Assoc 2021; 10 : e017416. [Google Scholar]
  29. Deecher DC. Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms. Expert Opin Investig Drugs 2005; 14 : 435–48. [Google Scholar]
  30. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006; 295 : 2057–71. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.